GE Healthcare, Optellum collaborate to advance lung cancer diagnosis with artificial intelligence
GE Healthcare, a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and Optellum, a commercial-stage lung health company, have signed a letter of intent to collaborate to advance precision diagnosis and treatment of lung cancer
Advance Lung Cancer Diagnosis With Artificial Inte | 29/11/2021 | By Darshana | 233
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy